Glenmark is an Indian multinational pharmaceutical company with its headquarters in Mumbai. The company was founded by Gracias Saldanha in the year 1977. The company was named after his sons Glenn Saldanha, CEO, Glenmark Pharmaceuticals, and Mark Saldanha, Founder, CEO, Marksans Pharma. It was incorporated on November 18, in the year 1977. When the company was taken over by Glenn Saldanha in 1998, it was a drug producing company that focused mainly on India. The company started its growth with the manufacture of generic medicines but it did not make biosimilars. Instead it was focused on innovations and formulations of its own. The company ventured into the therapeutic area of dermatology with the launch of their product called Candid Cream in the year 1979. To overcome problems of finance that came along with innovation, the company adopted the strategy of partnership with big pharmaceutical companies and out-licensing.

The company specializes in the areas of inflammation, dermatology, pain management, metabolic diseases, respiratory, cardiology, gynecology, diabetes, CNS, diabetes, oncology and anti-infectives. The Drug Discovery target areas include pain management and inflammation while its Formulation Business focuses on the therapeutic areas of dermatology, anti–infective, respiratory disorders, cardiology, diabetes, gynecology, CNS, and oncology.

Glenmark has a total number of fourteen manufacturing facilities located in four countries and has Research and Development centers at Navi in Mumbai, at Sinnar in Maharashtra, at Taloja in Mumbai, at Mahape in Mumbai, in Switzerland and at Oxford in UK. It has five manufacturing facilities at Ankleshwar and Dahej in Gujarat and Aurangabad, Kurkumbh and Mohol in Maharashtra. The company has an international presence in the US and Europe via its Formulations business and in Russia and Brazil with its Branded Generics business. The products of the country reach countries like North America, Europe, Latin America, Japan, South Korea, Russia, South Africa, Philippines, Malaysia, Vietnam, Myanmar and Sri Lanka, China and more. The company has its formulation business concentrated in markets of India, Latin America, Central Eastern Europe and Africa/Asia/CIS.

Some of the top products of the company include TELMA, TELMA-H, TELMA-AM, CANDID, ASCORIL +, ASCORIL-LS, CANDID-B, ALEX, ZITA-MET PLUS, ASCORIL D PLUS, CANDITRAL, FABIFLU, SYNTRAN, ZITEN-M, MOMATE, TELMA CT, CANDID MOUTH, MILIBACT, LULICAN, REMO, ONABET, TACROZ, VWASH PLUS, ZITA PLUS, EPTUS, CANDIBIOTIC PLUS, MILIXIM, COLY-MONAS, ZITEN, RAZEL, ALTACEF, SCALPE +, CANDID-TV, CANDID-V, TELMA-AMH, CANDIDERMA PLUS, HAIR-4U, T-PLANIN, DERIVA-CMS, RAZEL GOLD, MILIXIM-O, ALEX-JUNIOR, APREZO, MERROBE, ABIRAPROIFIN, KEFPOD, ASCORIL SF, SCABOMA and ASCORIL-C.